During the past decade, Massachusetts Eye Research and Surgery Institution conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Massachusetts Eye Research and Surgery Institution" #1 sponsor was "Lux Biosciences, Inc." with 3 trials, followed by "Eyegate Pharmaceuticals, Inc." with 2 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored and "Mallinckrodt" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Massachusetts Eye Research and Surgery Institution" are "Panuveitis" (5 trials), "Uveitis, Intermediate" (3 trials), "Uveitis, Posterior" (3 trials), "Uveitis" (2 trials) and "Uveitis, Anterior" (2 trials). Many other conditions were trialed in "Massachusetts Eye Research and Surgery Institution" in a lesser frequency.

Most popular intervention types in "Massachusetts Eye Research and Surgery Institution" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "LX211" (3 trials), "100 mM sodium citrate buffer solution" (1 trials), "40 mg/mL Dexamethasone phosphate ophthalmic solution" (1 trials) and "AEB071" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts Eye Research and Surgery Institution" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Massachusetts Eye Research and Surgery Institution". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Massachusetts Eye Research and Surgery Institution, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts Eye Research and Surgery Institution, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".